Alkermes Inc. plc (ALKS) is a publicly traded Healthcare sector company. As of September 2, 2026, ALKS trades at $47.22 with a market cap of $7.88B and a P/E ratio of 117.61. ALKS moved +0.49% today. Year to date, ALKS is +67.02%; over the trailing twelve months it is +60.54%. Its 52-week range spans $25.17 to $55.67. Analyst consensus is buy with an average price target of $58.25. Rallies surfaces ALKS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ALKS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $47.22 |
| Market Cap | $7.88B |
| P/E Ratio | 117.61 |
| EPS | $0.40 |
| Dividend Yield | 0.00% |
| 52-Week High | $55.67 |
| 52-Week Low | $25.17 |
| Volume | 652.29K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.67B |
| Net Income | $66.12M |
| Gross Margin | 84.56% |
12 analysts cover ALKS: 0 strong buy, 9 buy, 2 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $58.25.